Pfeifer B A, Admiraal S J, Gramajo H, Cane D E, Khosla C
Department of Chemical Engineering, Stanford University, Stanford, CA 94305-5025, USA.
Science. 2001 Mar 2;291(5509):1790-2. doi: 10.1126/science.1058092.
The macrocyclic core of the antibiotic erythromycin, 6-deoxyerythronolide B (6dEB), is a complex natural product synthesized by the soil bacterium Saccharopolyspora erythraea through the action of a multifunctional polyketide synthase (PKS). The engineering potential of modular PKSs is hampered by the limited capabilities for molecular biological manipulation of organisms (principally actinomycetes) in which complex polyketides have thus far been produced. To address this problem, a derivative of Escherichia coli has been genetically engineered. The resulting cellular catalyst converts exogenous propionate into 6dEB with a specific productivity that compares well with a high-producing mutant of S. erythraea that has been incrementally enhanced over decades for the industrial production of erythromycin.
抗生素红霉素的大环核心6-脱氧红霉内酯B(6dEB)是一种复杂的天然产物,由土壤细菌糖多孢红霉菌通过多功能聚酮合酶(PKS)的作用合成。模块化聚酮合酶的工程潜力受到了对复杂聚酮化合物至今仍能产生的生物体(主要是放线菌)进行分子生物学操作能力有限的阻碍。为了解决这个问题,已对大肠杆菌的一种衍生物进行了基因工程改造。由此产生的细胞催化剂将外源丙酸转化为6dEB,其比生产率与糖多孢红霉菌的高产突变体相当,该突变体在几十年里为红霉素的工业生产逐步得到了增强。